Metabolite-inspired compounds show promise for ulcerative colitis drug discovery
Two structurally modified compounds derived from an anti-inflammatory metabolite demonstrated enhanced anti-inflammatory activity in experimental ulcerative colitis in mice and human tissue, offering an underexplored drug discovery opportunity for this chronic inflammatory disease, according to a study led by researchers in the Institute for Biomedical Sciences at Georgia State University.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Childhood neglect may increase the risk of suicide attempts
United Kingdom
-
Tracing fetal DNA through maternal blood can help reduce prenatal testing errors
United Kingdom
-
Addressing mosquito-borne disease trends as climate change bites
United Kingdom
-
Large analysis finds no clear link between rotavirus vaccination and type 1 diabetes
United Kingdom
-
Very low carbohydrate diets linked to health benefits in children with type 1 diabetes
United Kingdom
-
Heel-prick blood samples from newborns could provide important insights into protection against serious infection
United Kingdom
-
Adolescents often choose to eat outside school, Swedish study finds
United Kingdom
-
For older adults, disaster risk starts long before disaster strikes
United Kingdom